However, a certain level of RUNX1 activity was required for the growth and survival of AML1-ETO and MLL-AF9 AML cells and combined loss of Runx1/Cbfb inhibited leukemia development induced by MLL-AF9 (Goyama et al., 2013). Here, KMT2A is linked to acute myeloid leukemia.